Announcements Trials

Browse Landscape

Phase

Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 1888 Carcinoma, Non-Small-Cell Lung 1348 Prostatic Neoplasms 980 Colorectal Neoplasms 851 Multiple Myeloma 741 Leukemia, Myeloid, Acute 725 Neoplasms 691 Lung Neoplasms 679 Neoplasm Metastasis 642 Lymphoma 579 Carcinoma, Hepatocellular 571 Pancreatic Neoplasms 566 Stomach Neoplasms 522 Leukemia 511 Recurrence 493 Leukemia, Lymphocytic, Chronic, B-Cell 459 Precursor Cell Lymphoblastic Leukemia-Lymphoma 452 Melanoma 451 Lymphoma, Non-Hodgkin 442 Ovarian Neoplasms 426 Lymphoma, Large B-Cell, Diffuse 423 Squamous Cell Carcinoma of Head and Neck 416 Myelodysplastic Syndromes 416 Head and Neck Neoplasms 403 Brain Neoplasms 403 Rectal Neoplasms 397 Glioblastoma 375 Carcinoma, Renal Cell 350 Hodgkin Disease 338 Esophageal Neoplasms 337

Interventions

trifluridine tipiracil drug combination 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × OTHER × First-line Treatment × Clear all

NCT05077839 2021-10-25

TOBACO

Tianjin Medical University Cancer Institute and Hospital

Phase 2 Unknown

Gastrointestinal

First-line Treatment

Data powered by HemOnc (CC BY 4.0) Colophon ⚡